Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Meier: Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide.... (0.10 sec) 

Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and …

- shouxi.net
JJ Meier, G Kemmeries, JJ Holst, MA Nauck - Diabetes, 2005 - Am Diabetes Assoc
Glucagon-like peptide 1 (GLP-1) has been proposed to act as an incretin hormone
due to its ability to enhance glucose-stimulated insulin secretion. Because
GLP-1 also decelerates gastric emptying, it physiologically reduces rather ...
Cited by 33 - Related articles - All 6 versions

Normalization of glucose concentrations and deceleration of gastric emptying after solid …

- endojournals.org
JJ Meier, B Gallwitz, S Salmen, O Goetze, JJ … - Journal of Clinical Endocrinology & Metabolism, 2003 - Endocrine Soc
The effects of different iv doses of glucagon-like peptide 1 (GLP-1) on glucose
homeostasis and gastric emptying were compared in patients with type 2 diabetes.
Twelve patients with type 2 diabetes received three different infusion ...
Cited by 121 - Related articles - BL Direct - All 5 versions

Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first- …


MA Nauck, A El-Ouaghlidi, B Gabrys, K … - Regulatory peptides, 2004 - Elsevier
Aims/Hypothesis: Since insulin secretion in response to exogenous gastric
inhibitory polypeptide (GIP) is diminished not only in patients with type 2
diabetes, but also in their normal glucose-tolerant first-degree relatives, ...
Cited by 33 - Related articles - All 3 versions

Effect of variations in small intestinal glucose delivery on plasma glucose, insulin, and …

- endojournals.org
DG O'Donovan, S Doran, C Feinle-Bisset, KL … - Journal of Clinical Endocrinology & Metabolism, 2004 - Endocrine Soc
The determinants of postprandial blood glycemia are controversial. We assessed
the effects of variations in the initial rate of small intestinal glucose
delivery on blood glucose, plasma insulin, and incretin responses in both ...
Cited by 52 - Related articles - All 9 versions

Lack of effect of exendin-4 and glucagon-like peptide-1-(7, 36)-amide on insulin action in …


A Vella, P Shah, A Reed, A Adkins, R Basu, R … - Diabetologia, 2002 - Springer
Aims/hypothesis. The aim of this study was to determine whether rapid conversion
to inactive and potentially an- tagonistic peptides could alter the response to
GLP-1. Methods. We evaluated the ability of exendin-4, a GLP-1 analogue ...
Cited by 41 - Related articles - BL Direct - All 4 versions

The glucagon-like peptide-1 metabolite GLP-1-(9-36) amide reduces postprandial glycemia …

- physiology.org
JJ Meier, A Gethmann, MA Nauck, O Gotze, F … - American Journal of Physiology- Endocrinology And …, 2006 - Am Physiological Soc
Glucagon-like peptide 1 (GLP-1) lowers glycemia by modulating gastric emptying
and endocrine pancreatic secretion. Rapidly after its secretion, GLP-1-(7–36)
amide is degraded to the metabolite GLP-1-(9–36) amide. The effects of ...
Cited by 21 - Related articles - BL Direct - All 3 versions

Effects of lipase inhibition on gastric emptying of, and on the glycaemic, insulin and …


DO'Donovan, M Horowitz, A Russo, C Feinle- … - Diabetologia, 2004 - Springer
Aims/hypotheses. We examined the effects of lipase inhibition with orlistat on
(i) gastric emptying of, and (ii) the glycaemic, glucagon-like peptide-1 (GLP-1)
and cardiovascular responses to, a high-fat/carbohy- drate meal in type 2 ...
Cited by 22 - Related articles - All 4 versions

Endogenous GLP-1 controls endocrine pancreatic secretion and antro-pyloro-duodenal …

- bmj.com [PDF] 
J Schirra, M Nicolaus, R Roggel, M … - British Medical Journal, 2005 - gut.bmj.com
Online First articles must include the digital object identifier (DOIs) and date
of initial publication. establish publication priority; they are indexed by
PubMed from initial publication. Citations to may be posted when available ...
Cited by 53 - Related articles - BL Direct - All 8 versions

Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric …

- endojournals.org
TJ Little, AN Pilichiewicz, A Russo, L … - Journal of Clinical Endocrinology & Metabolism, 2006 - Endocrine Soc
Results: GLP-1 0.3 and 0.9 slowed GE of solid (intragastric retention at t = 100
min; saline: 28 ± 5%; GLP-1 0.3: 53 ± 6%; GLP-1 0.9: 58 ± 7%; P < 0.001) and
liquid (time for 50% of the liquid to empty, saline: 28 ± 2 min; GLP-1 ...
Cited by 27 - Related articles - BL Direct - All 4 versions

Glucagon-like peptide 1 (GLP-1) in biology and pathology


JJ Meier, MA Nauck - Diabetes/Metabolism Reviews - interscience.wiley.com
Post-translational proteolytic processing of the preproglucagon gene in the gut
results in the formation of glucagon-like peptide 1 (GLP-1). Owing to its
glucose-dependent insulinotropic effect, this hormone was postulated to ...
Cited by 73 - Related articles - All 3 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google